94 related articles for article (PubMed ID: 20334584)
21. Vascular endothelial growth factor +405 G/C,-460 T/C and -2578 A/C polymorphisms are not associated with insulin resistance in polycystic ovary syndrome.
Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Uysal M
Int J Immunogenet; 2010 Aug; 37(4):239-43. PubMed ID: 20477880
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome.
Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S233-7. PubMed ID: 17606307
[TBL] [Abstract][Full Text] [Related]
23. The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients.
Cetinkalp S; Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Ozgen AG; Saygili F; Yilmaz C
Gynecol Endocrinol; 2010 Mar; 26(3):167-72. PubMed ID: 19718569
[TBL] [Abstract][Full Text] [Related]
24. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
25. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome.
Wang K; You L; Shi Y; Wang L; Zhang M; Chen ZJ
Fertil Steril; 2008 Aug; 90(2):378-84. PubMed ID: 17953957
[TBL] [Abstract][Full Text] [Related]
26. The M235T polymorphism of the angiotensinogen gene in women with polycystic ovary syndrome.
Zulian E; Sartorato P; Schiavi F; Moghetti P; Castello R; Mantero F; Opocher G; Scaroni C
Fertil Steril; 2005 Nov; 84(5):1520-1. PubMed ID: 16275260
[TBL] [Abstract][Full Text] [Related]
27. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome.
Jones MR; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
Fertil Steril; 2008 Dec; 90(6):2298-303. PubMed ID: 18249389
[TBL] [Abstract][Full Text] [Related]
29. Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome.
Walch K; Grimm C; Nagele F; Huber J; Wölfler M; Vytiska-Binstorfer E; Unfried G; Hefler L
Acta Obstet Gynecol Scand; 2006; 85(7):869-73. PubMed ID: 16817088
[TBL] [Abstract][Full Text] [Related]
30. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.
Kaya C; Pabuccu R; Cengiz SD; Dünder I
Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):161-6. PubMed ID: 20146169
[TBL] [Abstract][Full Text] [Related]
32. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
Vagiri D; Barletta C; Cioli I; Scavo D
Minerva Endocrinol; 1994 Mar; 19(1):5-12. PubMed ID: 8035770
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor-γ and -δ polymorphisms in women with polycystic ovary syndrome.
Christopoulos P; Mastorakos G; Gazouli M; Deligeoroglou E; Katsikis I; Diamanti-Kandarakis E; Panidis D; Creatsas G
Ann N Y Acad Sci; 2010 Sep; 1205():185-91. PubMed ID: 20840271
[TBL] [Abstract][Full Text] [Related]
34. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
35. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome.
Wang K; Wang L; Zhao Y; Shi Y; Wang L; Chen ZJ
Hum Reprod; 2009 Feb; 24(2):485-90. PubMed ID: 19049992
[TBL] [Abstract][Full Text] [Related]
36. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
37. Genetic determinants of insulin action in polycystic ovary syndrome.
Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
[TBL] [Abstract][Full Text] [Related]
38. Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population.
Baba T; Endo T; Sata F; Honnma H; Kitajima Y; Hayashi T; Manase K; Kanaya M; Yamada H; Minakami H; Kishi R; Saito T
Life Sci; 2007 Aug; 81(10):850-4. PubMed ID: 17719609
[TBL] [Abstract][Full Text] [Related]
39. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
[TBL] [Abstract][Full Text] [Related]
40. PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women.
Dadachanji R; Shaikh N; Patil A; Shah N; Mukherjee S
Gene; 2018 Jun; 661():34-44. PubMed ID: 29604466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
